Robinhood Markets, Inc.’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Robinhood Markets, Inc.'s ALNY Position: Q3 2026 in Review
Robinhood Markets, Inc. opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 1 share worth $259. The stake represents ﹤0.01% of the portfolio and ranks #963 among its holdings.
729 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Robinhood Markets, Inc. held 1 share of Alnylam Pharmaceuticals worth $259 as of Q3 2026.
- Alnylam Pharmaceuticals was a new Robinhood Markets, Inc. position in Q3 2026.
- Alnylam Pharmaceuticals made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #963 holding.
- 729 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.